Analysis of low-abundance, low-molecular-weight serum proteins using mass spectrometry.

To detect diseases early in the general population, new diagnostic approaches are needed that have adequate sensitivity and specificity. Recent studies have used mass spectrometry to identify a serum proteomic pattern for breast and ovarian cancer. Serum contains 60-80 mg/mL protein, but 57-71% of this is serum albumin, and 8-26% are gamma-globulins. These large proteins must be depleted before smaller, less-abundant proteins can be detected using mass spectrometry, but because serum albumin is known to act as a carrier for smaller proteins, removal of these molecules using columns or filtration may result in the loss of molecules of interest. The objective of this study was to develop a reproducible method to deplete serum samples of high-abundance proteins in order to analyze the less-abundant proteins present in serum. We used organic solvents to precipitate the large proteins out of solution. We also predicted that this would cause many smaller proteins to dissociate from their carrier molecules, allowing for detection of a larger number of peptides and small proteins. These treated samples were analyzed using capillary liquid chromatography coupled with electrospray ionization mass spectrometry. Analysis demonstrated reproducible results. Acetonitrile treatment clearly released many carrier-bound molecular species and was superior to ultrafiltration alone for serum proteomic analysis.

[1]  Emanuel F. Petricoin,et al.  Clinical Applications of Proteomics: Proteomic Pattern Diagnostics , 2002, Journal of Mammary Gland Biology and Neoplasia.

[2]  M. Ferrari,et al.  Clinical proteomics: Written in blood , 2003, Nature.

[3]  G. Rice,et al.  An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum , 2003, Proteomics.

[4]  T. Veenstra,et al.  Characterization of the Low Molecular Weight Human Serum Proteome*S , 2003, Molecular & Cellular Proteomics.

[5]  H. D. de Bruijn,et al.  Sample preparation of human serum for the analysis of tumor markers. Comparison of different approaches for albumin and gamma-globulin depletion. , 2003, Journal of chromatography. A.

[6]  E. Diamandis Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? , 2003, Clinical chemistry.

[7]  Bao-Ling Adam,et al.  Diagnostic potential of serum proteomic patterns in prostate cancer. , 2003, The Journal of urology.

[8]  A. Alpert,et al.  Precipitation of Large, High-Abundance Proteins from Serum with Organic Solvents , 2003 .

[9]  Emanuel F Petricoin,et al.  Clinical applications of proteomics. , 2003, The Journal of nutrition.

[10]  E. Petricoin,et al.  Counterpoint: The vision for a new diagnostic paradigm. , 2003, Clinical chemistry.

[11]  Ronald J. Moore,et al.  Toward a Human Blood Serum Proteome , 2002, Molecular & Cellular Proteomics.

[12]  D. Chan,et al.  Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. , 2002, Clinical chemistry.

[13]  G. Rice,et al.  Proteomic analysis of human plasma: Failure of centrifugal ultrafiltration to remove albumin and other high molecular weight proteins , 2001, Proteomics.